![Victor Sandor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Victor Sandor
Director/Board Member at
ADC THERAPEUTICS SA
Net worth: 478 332 $ as of 2026-05-30
Profile
Victor Sandor is currently an Independent Non-Executive Director at ADC Therapeutics SA since 2020, an Independent Director at Prelude Therapeutics, Inc. since 2020, an Independent Director at Kymera Therapeutics, Inc. since 2022, a Director at Istari Oncology, Inc. since 2019, and an Independent Director at AbCellera Biologics, Inc. starting in 2026.
Former roles include Independent Non-Executive Director at Merus NV from 2019 to 2025, SVP-Global Clinical Development at Incyte Corp.
from 2014 to 2019, Chief Medical Officer at Array BioPharma, Inc. from 2014 to 2019, Head-Oncology Product Development at AstraZeneca, Inc., and Chief Medical Officer-Oncology & VP at Biogen Idec, Inc. (North Carolina) from 2010 to 2014.
Education includes a doctorate from McGill University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ADC THERAPEUTICS LTD 0.11% | 2026-06-02 | 140,686 ( 0.11% ) | 478 332 $ | 2026-05-30 |
| 2026-06-08 | 0 ( -.--% ) | - $ | 2026-05-30 | |
| 2026-03-30 | 0 ( -.--% ) | - $ | 2026-05-30 |
Victor Sandor active positions
| Companies | Position | Start |
|---|---|---|
| ADC THERAPEUTICS SA | Director/Board Member | 2020-04-26 |
| PRELUDE THERAPEUTICS INCORPORATED | Director/Board Member | 2020-04-30 |
| KYMERA THERAPEUTICS, INC. | Director/Board Member | 2022-11-02 |
| ABCELLERA BIOLOGICS INC. | Director/Board Member | 2026-05-31 |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Focuses on novel immuno-oncology and immunotherapy platforms for treatment of glioblastoma and tumors | Director/Board Member | 2019-06-30 |
Former positions of Victor Sandor
| Companies | Position | End |
|---|---|---|
| MERUS N.V. | Director/Board Member | 2025-12-11 |
| INCYTE CORPORATION | Chief Tech/Sci/R&D Officer | 2019-08-31 |
| ARRAY TECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 2019-07-31 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 2014-08-31 |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Victor Sandor
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
46
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
AbCellera Biologics, Inc.
 AbCellera Biologics, Inc. BiotechnologyHealth Technology Discovers and develops antibody drugs & therapeutics | Health Technology |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Focuses on novel immuno-oncology and immunotherapy platforms for treatment of glioblastoma and tumors | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
- Stock Market
- Insiders
- Victor Sandor
